Skip to Main Content

Paper Details

Functional genomic analysis identifies drug targetable pathways in invasive and metastatic cutaneous squamous cell carcinoma.
Cold Spring Harb Mol Case Stud
4
2020
EPHA6, EPHA7, Eph, cSCC, cutaneous squamous cell carcinoma, ephrin, neutrophil, patient, primary cultured cells, siRNAs, tumors
Aged, Aged, 80 and over, Carcinoma, Squamous Cell, Cell Survival, Disease Progression, Exome Sequencing, Gene Expression, Gene Expression Regulation, Neoplastic, Genomics, Humans, Male, Middle Aged, Mutation, Receptor, EphA6, Receptor, EphA7, Signal Transduction, Skin Neoplasms, Small Molecule Libraries
Author NameAffiliation
Ashley N AndersonOregon Health and Science University
Danielle McClanahanOregon Health and Science University
James JacobsDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University Knight Cancer Institute
Sophia JengDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University Knight Cancer Institute
Sophia JengOregon Clinical and Translational Research Institute, Oregon Health and Science University
Myles VigodaOregon Health and Science University
Aurora S BlucherOregon Health and Science University Knight Cancer Institute
Christina L ZhengDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University Knight Cancer Institute
Yeon Jung YooOregon Health and Science University
Carolyn HaleOregon Health and Science University
Xiaoming OuyangOregon Health and Science University
Daniel R ClayburghOregon Health & Science University
Daniel R ClayburghVeterans Affairs Medical Center
Peter E AndersenOregon Health & Science University
Jeffrey W TynerOregon Health and Science University Knight Cancer Institute
Jeffrey W TynerOregon Health and Science University Knight Cancer Institute
Anna BarOregon Health and Science University
Olivia M LuceroOregon Health and Science University
Justin J LeitenbergerOregon Health and Science University
Shannon K McWeeneyDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University Knight Cancer Institute
Molly Kulesz-MartinOregon Health and Science University
Molly Kulesz-MartinOregon Health and Science University Knight Cancer Institute
  • 1 - 22

Datasets

Release 1.2